Your browser doesn't support javascript.
loading
Nano-ghosts: Novel biomimetic nano-vesicles for the delivery of antisense oligonucleotides.
Oieni, Jacopo; Lolli, Andrea; D'Atri, Domenico; Kops, Nicole; Yayon, Avner; van Osch, Gerjo J V M; Machluf, Marcelle.
Afiliação
  • Oieni J; Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Lolli A; Department of Orthopaedics, Erasmus MC, University Medical Center, Rotterdam 3015GD, the Netherlands; Department of Oral and Maxillofacial Surgery, Erasmus MC, University Medical Center, Rotterdam 3015GD, the Netherlands.
  • D'Atri D; Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Kops N; Department of Orthopaedics, Erasmus MC, University Medical Center, Rotterdam 3015GD, the Netherlands.
  • Yayon A; Procore Ltd., Weizmann Science Park, 7 Golda Meir St., Ness Ziona 7414002, Israel.
  • van Osch GJVM; Department of Orthopaedics, Erasmus MC, University Medical Center, Rotterdam 3015GD, the Netherlands; Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC, University Medical Center, Rotterdam, 3015GD, the Netherlands; Department of Biomechanical Engineering, Faculty of Mechanical, M
  • Machluf M; Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel. Electronic address: machlufm@tx.technion.ac.il.
J Control Release ; 333: 28-40, 2021 05 10.
Article em En | MEDLINE | ID: mdl-33741386
ABSTRACT
Antisense oligonucleotides (ASOs) carry an enormous therapeutic potential in different research areas, however, the lack of appropriate carriers for their delivery to the target tissues is hampering their clinical translation. The present study investigates the application of novel biomimetic nano-vesicles, Nano-Ghosts (NGs), for the delivery of ASOs to human mesenchymal stem cells (MSCs), using a microRNA inhibitor (antimiR) against miR-221 as proof-of-concept. The integration of this approach with a hyaluronic acid-fibrin (HA-FB) hydrogel scaffold is also studied, thus expanding the potential of NGs applications in regenerative medicine. The study shows robust antimiR encapsulation in the NGs using electroporation and the NGs ability to be internalized in MSCs and to deliver their cargo while avoiding endo-lysosomal degradation. This leads to rapid and strong knock-down of miR-221 in hMSCs in vitro, both in 2D and 3D hydrogel culture conditions (>90% and > 80% silencing efficiency, respectively). Finally, in vivo studies performed with an osteochondral defect model demonstrate the NGs ability to effectively deliver antimiR to endogenous cells. Altogether, these results prove that the NGs can operate as stand-alone system or as integrated platform in combination with scaffolds for the delivery of ASOs for a wide range of applications in drug delivery and regenerative medicine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2021 Tipo de documento: Article